114 related articles for article (PubMed ID: 6982312)
1. Circulating immune complexes in patients with multiple sclerosis. A longitudinal study of serum and CSF by C1q and platelet binding tests.
Arnadottir T; Kekomäki R; Lund GA; Reunanen M; Salmi AA
J Neurol Sci; 1982 Sep; 55(3):273-83. PubMed ID: 6982312
[TBL] [Abstract][Full Text] [Related]
2. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complexes in serum and in cerebrospinal fluid of patients with multiple sclerosis. Characterization and correlation with the clinical course.
Procaccia S; Lanzanova D; Caputo D; Ferrante P; Papini E; Gasparini A; Colucci A; Bianchi M; Villa P; Blasio R
Acta Neurol Scand; 1988 May; 77(5):373-81. PubMed ID: 3046225
[TBL] [Abstract][Full Text] [Related]
4. Immune complexes in serum and cerebrospinal fluid of multiple sclerosis patients and patients with other neurological diseases.
Salmi A; Ziola B; Reunanen M; Julkunen I; Wager O
Acta Neurol Scand; 1982 Jul; 66(1):1-15. PubMed ID: 7113673
[TBL] [Abstract][Full Text] [Related]
5. Immune complexes in multiple sclerosis: relation to clinical pattern.
Patzold U; Haller P; Baruth B; Liman W; Deicher H
J Neurol; 1980; 222(4):249-60. PubMed ID: 6154784
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM
Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161
[TBL] [Abstract][Full Text] [Related]
7. Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlation with polyclonal B cell activation and with intracerebral immunoglobulin synthesis.
Lambert PH; Berney M; Kazyumba G
J Clin Invest; 1981 Jan; 67(1):77-85. PubMed ID: 6969733
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis. Cerebrospinal fluid immune complexes that bind C1q.
Rudick RA; Bidlack JM; Knutson DW
Arch Neurol; 1985 Sep; 42(9):856-8. PubMed ID: 3875333
[TBL] [Abstract][Full Text] [Related]
9. Platelet interactions with C1q in whole blood and in the presence of immune complexes or aggregated IgG.
Peerschke EI; Ghebrehiwet B
Clin Immunol Immunopathol; 1992 Apr; 63(1):45-50. PubMed ID: 1591882
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the soluble immune complexes that are detected by three different techniques.
van der Giessen M; The TH
Clin Immunol Immunopathol; 1986 Feb; 38(2):244-55. PubMed ID: 3484441
[TBL] [Abstract][Full Text] [Related]
11. Characterization of immune complexes in multiple sclerosis by an antigen-specific immune complex radioimmunoassay.
Lund GA; Arnadottir T; Hukkanen V; Reunanen M; Salmi A
J Neuroimmunol; 1983 Jun; 4(3):253-64. PubMed ID: 6853697
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes in multiple sclerosis: relation with disease activity.
Dasgupta MK; Warren KG; Johny KV; Dossetor JB
Neurology; 1982 Sep; 32(9):1000-4. PubMed ID: 6981073
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid and serum immune complex in acute inflammatory polyneuritis. Detection by Clq binding assay.
Antoine JC; Michel D; Lamelin JP; Laurent B; Schott B
Acta Neurol Scand; 1986 May; 73(5):477-80. PubMed ID: 3487905
[TBL] [Abstract][Full Text] [Related]
14. An analysis of the fluid phase C1q binding assay. The effect of endogenous C1q on the precipitation and detection of an immune complex model.
Jacobs RJ; Mocharla R
J Immunol Methods; 1988 May; 109(2):265-75. PubMed ID: 3258897
[TBL] [Abstract][Full Text] [Related]
15. Soluble immune complexes in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.
Glikmann G; Svehag SE; Hansen E; Hansen O; Husby S; Nielsen H; Farrell C
Acta Neurol Scand; 1980 Jun; 61(6):333-43. PubMed ID: 6998248
[TBL] [Abstract][Full Text] [Related]
16. The influence of high-dose prednisone medication on autoantibody specific activity and on circulating immune complex level in cerebrospinal fluid of multiple sclerosis patients.
Wajgt A; Górny MK; Jenek R
Acta Neurol Scand; 1983 Dec; 68(6):378-85. PubMed ID: 6666546
[TBL] [Abstract][Full Text] [Related]
17. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
Greisman SG; Redecha PB; Kimberly RP; Christian CL
J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
[TBL] [Abstract][Full Text] [Related]
18. Polyethylene glycol enhances the binding of C1q to circulating immune complexes.
Hack CE; Eerenberg-Belmer AJ; Hannema AJ; Out TA; Aalberse RC
J Immunol Methods; 1981; 44(2):211-21. PubMed ID: 6792284
[TBL] [Abstract][Full Text] [Related]
19. C1q-binding immune complexes and other immunological studies in children with pulmonary hemosiderosis.
Blanco A; Solís P; Gómez S; Linares P; Sánchez Villares E
Allergol Immunopathol (Madr); 1984; 12(1):37-44. PubMed ID: 6375320
[TBL] [Abstract][Full Text] [Related]
20. C1q microtiter plate ELISA system for detecting circulating immune complexes and its application of testing the sera in neurological diseases.
Araga S; Irie H; Takahashi K
Jpn J Exp Med; 1984 Feb; 54(1):23-7. PubMed ID: 6384588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
